TR199901768T2 - Bir kemoterapötik etken ile bir benzimidazolu ve istege bagli olarak bir potansiyatörü içeren, kanser gelisimini önlemeye yönelik kit. - Google Patents
Bir kemoterapötik etken ile bir benzimidazolu ve istege bagli olarak bir potansiyatörü içeren, kanser gelisimini önlemeye yönelik kit.Info
- Publication number
- TR199901768T2 TR199901768T2 TR1999/01768T TR9901768T TR199901768T2 TR 199901768 T2 TR199901768 T2 TR 199901768T2 TR 1999/01768 T TR1999/01768 T TR 1999/01768T TR 9901768 T TR9901768 T TR 9901768T TR 199901768 T2 TR199901768 T2 TR 199901768T2
- Authority
- TR
- Turkey
- Prior art keywords
- benzimidazole
- cancer
- development
- prevent
- chemotherapeutic agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Memelilerde tümör ve kanserlerin gelisimini önlemekte kullanilan bir yöntem olup, tümörün veya kanserin kütlesini önemli ölçüde azaltmak üzere bir kemoterapötik etkenin verilmesini ve daha sonra bir benzimidazol türevinin verilmesini içermektedir. Benzimidazol bilesimine potansiyatörler de dahil edilebilir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/788,482 US5900429A (en) | 1997-01-28 | 1997-01-28 | Method for inhibiting the growth of cancers |
Publications (1)
Publication Number | Publication Date |
---|---|
TR199901768T2 true TR199901768T2 (tr) | 1999-09-21 |
Family
ID=25144634
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR1999/01768T TR199901768T2 (tr) | 1997-01-28 | 1998-01-21 | Bir kemoterapötik etken ile bir benzimidazolu ve istege bagli olarak bir potansiyatörü içeren, kanser gelisimini önlemeye yönelik kit. |
Country Status (19)
Country | Link |
---|---|
US (3) | US5900429A (tr) |
EP (1) | EP0967977A1 (tr) |
JP (1) | JP2001509164A (tr) |
KR (1) | KR20000070551A (tr) |
CN (1) | CN1244123A (tr) |
AR (1) | AR011583A1 (tr) |
AU (1) | AU729099B2 (tr) |
BR (1) | BR9807003A (tr) |
CA (1) | CA2277166A1 (tr) |
CZ (1) | CZ265499A3 (tr) |
HU (1) | HUP0001939A3 (tr) |
ID (1) | ID23507A (tr) |
IL (1) | IL131097A0 (tr) |
NO (1) | NO993654L (tr) |
PL (1) | PL335054A1 (tr) |
SK (1) | SK99199A3 (tr) |
TR (1) | TR199901768T2 (tr) |
WO (1) | WO1998032440A1 (tr) |
ZA (1) | ZA98643B (tr) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6262093B1 (en) | 1995-04-12 | 2001-07-17 | The Proctor & Gamble Company | Methods of treating cancer with benzimidazoles |
US6177460B1 (en) | 1995-04-12 | 2001-01-23 | The Procter & Gamble Company | Method of treatment for cancer or viral infections |
US6479526B1 (en) | 1995-04-12 | 2002-11-12 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of viruses and cancers |
US5770616A (en) | 1995-06-07 | 1998-06-23 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of cancers |
US6265427B1 (en) | 1995-06-07 | 2001-07-24 | The Proctor & Gamble Company | Pharmaceutical composition for the method of treating leukemia |
US6686391B2 (en) | 1995-08-04 | 2004-02-03 | University Of Arizona Foundation | N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions |
US5900429A (en) * | 1997-01-28 | 1999-05-04 | The Procter & Gamble Company | Method for inhibiting the growth of cancers |
DE19710907A1 (de) * | 1997-03-15 | 1998-09-17 | Pascoe Pharm Praeparate Gmbh | Ascorbinsäure als Adjuvans in der Chemo- und Strahlentherapie von Malignomen |
US6506783B1 (en) | 1997-05-16 | 2003-01-14 | The Procter & Gamble Company | Cancer treatments and pharmaceutical compositions therefor |
US6245789B1 (en) | 1998-05-19 | 2001-06-12 | The Procter & Gamble Company | HIV and viral treatment |
CA2362047A1 (en) * | 1999-02-26 | 2000-08-31 | Larry Helson | Treatment regimen for prostate cancer, initiated after androgen ablative therapy has started |
WO2000050022A2 (en) * | 1999-02-26 | 2000-08-31 | Napro Biotherapeutics, Inc. | Treatment regimen for hormone-sensitive cancers |
JP2003524624A (ja) * | 1999-04-09 | 2003-08-19 | ジェシー エル エス オウ | 治療薬の組織への送達を高める方法及び組成物 |
US7217735B1 (en) | 1999-04-09 | 2007-05-15 | Au Jessie L-S | Methods and compositions for enhancing delivery of therapeutic agents to tissues |
US6423734B1 (en) * | 1999-08-13 | 2002-07-23 | The Procter & Gamble Company | Method of preventing cancer |
CA2401304A1 (en) * | 2000-03-02 | 2001-09-07 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Combination chemotherapy |
US6384049B1 (en) * | 2000-05-25 | 2002-05-07 | The Procter & Gamble Company | Cancer treatment |
US6462062B1 (en) | 2000-09-26 | 2002-10-08 | The Procter & Gamble Company | Compounds and methods for use thereof in the treatment of cancer or viral infections |
US6380232B1 (en) | 2000-09-26 | 2002-04-30 | The Procter & Gamble Company | Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof |
US6407105B1 (en) | 2000-09-26 | 2002-06-18 | The Procter & Gamble Company | Compounds and methods for use thereof in the treatment of cancer or viral infections |
US6608096B1 (en) | 2000-09-26 | 2003-08-19 | University Of Arizona Foundation | Compounds and methods for use thereof in the treatment of cancer or viral infections |
AU2002248341B8 (en) * | 2001-01-11 | 2007-03-29 | Board Of Regents, The University Of Texas System | Antihelminthic drugs as a treatment for hyperproliferative diseases |
US6515074B2 (en) * | 2001-01-22 | 2003-02-04 | Delphi Technologies, Inc. | Thermoplastic polymer alloy compositions and process for manufacture thereof |
US6693125B2 (en) * | 2001-01-24 | 2004-02-17 | Combinatorx Incorporated | Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders |
DK1407784T3 (da) * | 2001-06-25 | 2011-02-28 | Ajinomoto Kk | Antitumormidler |
EP1830847B1 (en) * | 2004-12-06 | 2014-11-19 | Pitney Pharmaceuticals Pty Limited | Treatment for cancer |
CN100350975C (zh) * | 2005-02-03 | 2007-11-28 | 山东蓝金生物工程有限公司 | 抗癌药物组合物 |
EP2131840B1 (en) * | 2007-03-07 | 2018-10-17 | MEI Pharma, Inc. | Combination of benzimidazole anti-cancer agent and a second anti-cancer agent |
EP3621603A4 (en) | 2017-05-08 | 2021-01-20 | Meharry Medical College | HYDROXYUREA SERVING TO IMPROVE SPERMATIC CELLS |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3010968A (en) * | 1959-11-25 | 1961-11-28 | Du Pont | Process for manufacture of certain alkyl esters of benzimidazole carbamic acids |
NL134354C (tr) | 1963-05-23 | |||
US3499761A (en) | 1964-07-20 | 1970-03-10 | Gaf Corp | Silver halide emulsions containing alkyl esters of benzimidazole carbamic acid antifogging agents |
US3541213A (en) | 1966-05-06 | 1970-11-17 | Du Pont | Fungicidal and mite ovicidal substituted 2-aminobenzimidazoles |
US3881014A (en) | 1968-11-05 | 1975-04-29 | Bayer Ag | N-tritylimidazoles for treating fungal infections |
BE759337A (fr) * | 1969-11-24 | 1971-05-24 | Lilly Co Eli | Benzimidazol (2,1-b)-quinazolin (6h) ones qui sont des immuno-depresseurs, et nouvelles benzimidazo (2,1-b) quinazolin-12-(6h) ones |
US3956262A (en) * | 1970-12-09 | 1976-05-11 | Beecham Group Limited | Triazenoimidazoles |
US3738995A (en) * | 1971-05-14 | 1973-06-12 | Du Pont | Solvent process for the preparation of 1 - carbamoyl-substituted 2 - benzimidazolecarbamates |
FR2155888A1 (en) * | 1971-10-13 | 1973-05-25 | Agot Aime | Solid anthelmintic composn - for more economical treatment of ruminants |
US4046906A (en) * | 1973-04-21 | 1977-09-06 | Hoechst Aktiengesellschaft | Salts of alkyl 2-benzimidazole-carbamate |
HU193951B (en) * | 1985-03-11 | 1987-12-28 | Richter Gedeon Vegyeszet | Process for producing new sulfur-containing 5-substituted benzimidazol derivatives and pharmaceutical compositions containing them |
US4731366A (en) * | 1986-08-05 | 1988-03-15 | Harbor Branch Oceanographic Institution, Inc. | Discorhabdin compositions and their methods of use |
GB2210875B (en) * | 1987-10-09 | 1991-05-29 | Farmos Oy | Aromatase inhibiting 4(5)-imidazoles |
US5329012A (en) * | 1987-10-29 | 1994-07-12 | The Research Foundation Of State University Of New York | Bis(acyloxmethyl)imidazole compounds |
US5114951A (en) | 1989-04-11 | 1992-05-19 | Burroughs Wellcome Company | Agents for combating multiple drug resistance |
US5149527A (en) * | 1990-09-18 | 1992-09-22 | Oncotech, Inc. | Immunopotentiating protocol for chemotherapy-responsive tumors |
US5310748A (en) * | 1992-05-11 | 1994-05-10 | The Du Pont Merck Pharmaceutical Company | Imidazoles for the treatment of atherosclerosis |
US5364875A (en) * | 1992-05-11 | 1994-11-15 | The Du Pont Merck Pharmaceutical Company | Imidazoles linked to bicyclic heterocyclic groups for the treatment of atherosclerosis |
US5290801A (en) * | 1992-05-29 | 1994-03-01 | The Du Pont Merck Pharmaceutical Company | Benzimidazoles for the treatment of atherosclerosis |
EP0655066A1 (en) * | 1992-08-12 | 1995-05-31 | PHARMACIA & UPJOHN COMPANY | Protein kinase inhibitors and related compounds combined with taxol |
CN1090186C (zh) | 1993-03-31 | 2002-09-04 | 麦克公司 | 治疗aids药物组合物中的hiv蛋白酶抑制剂 |
US5434163A (en) | 1993-05-14 | 1995-07-18 | The Medical College Of Pennsylvania | Treatment of Cryptococcus neoformans infection |
JP3213471B2 (ja) * | 1994-04-13 | 2001-10-02 | ポーラ化成工業株式会社 | 薬効成分含有リポソーム製剤の製造方法 |
ZA962879B (en) * | 1995-04-12 | 1997-03-17 | Procter & Gamble | A pharmaceutical composition for inhibiting the growth of viruses and cancers |
US5629341A (en) * | 1995-04-12 | 1997-05-13 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of viruses and cancers |
US5656615A (en) | 1995-04-12 | 1997-08-12 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of cancers and viruses in mammals |
ZA962880B (en) | 1995-04-12 | 1997-03-17 | Procter & Gamble | A pharmaceutical composition for inhibiting the growth of viruses and cancers |
NZ305784A (en) * | 1995-04-12 | 2001-03-30 | Procter & Gamble | Benzimidazole containing medicaments for treating cancers, tumors and viral infections |
US5665713A (en) * | 1995-04-12 | 1997-09-09 | Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of viruses and cancers |
AU714056B2 (en) | 1995-04-12 | 1999-12-16 | Uaf Technologies And Research Llc | A pharmaceutical composition containing N-chlorophenylcarbamates and N-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers |
US5665751A (en) | 1995-06-07 | 1997-09-09 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of cancers |
MX9707809A (es) * | 1995-06-07 | 1998-01-31 | Procter & Gamble | Una composicion farmaceutica que contiene bencimidazol para inhibir el crecimiento de canceres. |
KR19990022617A (ko) | 1995-06-07 | 1999-03-25 | 데이비드 엠 모이어 | 백혈병 치료용 약제의 제조를 위한 벤즈이미다졸의 용도 |
US5770616A (en) | 1995-06-07 | 1998-06-23 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of cancers |
US6200992B1 (en) | 1995-06-07 | 2001-03-13 | The Procter & Gamble Company | Pharmaceutical composition for inhibiting the growth of cancers |
PL324905A1 (en) | 1995-08-03 | 1998-06-22 | Procter & Gamble | Application of griseofulvin in carcinoma development inhibition |
IL123095A0 (en) | 1995-08-04 | 1998-09-24 | Procter & Gamble | Pharmaceutical compositions containing fluconazole for inhibiting the growth of cancers |
US5908855A (en) | 1996-07-16 | 1999-06-01 | The Procter & Gamble Company | Compositions for treating viral infections |
US5900429A (en) | 1997-01-28 | 1999-05-04 | The Procter & Gamble Company | Method for inhibiting the growth of cancers |
US6506783B1 (en) | 1997-05-16 | 2003-01-14 | The Procter & Gamble Company | Cancer treatments and pharmaceutical compositions therefor |
PE11499A1 (es) | 1997-05-16 | 1999-03-01 | Procter & Gamble | Tratamiento del hiv y cancer |
US6245789B1 (en) | 1998-05-19 | 2001-06-12 | The Procter & Gamble Company | HIV and viral treatment |
-
1997
- 1997-01-28 US US08/788,482 patent/US5900429A/en not_active Expired - Fee Related
-
1998
- 1998-01-21 HU HU0001939A patent/HUP0001939A3/hu unknown
- 1998-01-21 SK SK991-99A patent/SK99199A3/sk unknown
- 1998-01-21 AU AU60343/98A patent/AU729099B2/en not_active Ceased
- 1998-01-21 EP EP98903620A patent/EP0967977A1/en not_active Withdrawn
- 1998-01-21 WO PCT/US1998/001147 patent/WO1998032440A1/en not_active Application Discontinuation
- 1998-01-21 TR TR1999/01768T patent/TR199901768T2/tr unknown
- 1998-01-21 ID IDW990746A patent/ID23507A/id unknown
- 1998-01-21 CN CN98802043A patent/CN1244123A/zh active Pending
- 1998-01-21 CZ CZ992654A patent/CZ265499A3/cs unknown
- 1998-01-21 PL PL98335054A patent/PL335054A1/xx unknown
- 1998-01-21 IL IL13109798A patent/IL131097A0/xx unknown
- 1998-01-21 BR BR9807003-7A patent/BR9807003A/pt not_active IP Right Cessation
- 1998-01-21 CA CA002277166A patent/CA2277166A1/en not_active Abandoned
- 1998-01-21 KR KR1019997006797A patent/KR20000070551A/ko not_active Application Discontinuation
- 1998-01-21 JP JP53211098A patent/JP2001509164A/ja active Pending
- 1998-01-27 ZA ZA98643A patent/ZA98643B/xx unknown
- 1998-01-28 AR ARP980100378A patent/AR011583A1/es not_active Application Discontinuation
- 1998-12-22 US US09/218,884 patent/US6271217B1/en not_active Expired - Fee Related
-
1999
- 1999-07-27 NO NO993654A patent/NO993654L/no not_active Application Discontinuation
-
2000
- 2000-04-19 US US09/552,408 patent/US6329355B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
NO993654D0 (no) | 1999-07-27 |
CN1244123A (zh) | 2000-02-09 |
CZ265499A3 (cs) | 1999-12-15 |
EP0967977A1 (en) | 2000-01-05 |
US5900429A (en) | 1999-05-04 |
HUP0001939A3 (en) | 2002-08-28 |
AU6034398A (en) | 1998-08-18 |
JP2001509164A (ja) | 2001-07-10 |
IL131097A0 (en) | 2001-01-28 |
BR9807003A (pt) | 2000-03-14 |
AU729099B2 (en) | 2001-01-25 |
CA2277166A1 (en) | 1998-07-30 |
KR20000070551A (ko) | 2000-11-25 |
WO1998032440A1 (en) | 1998-07-30 |
NO993654L (no) | 1999-09-28 |
ZA98643B (en) | 1998-07-30 |
HUP0001939A2 (hu) | 2001-01-29 |
US6329355B1 (en) | 2001-12-11 |
AR011583A1 (es) | 2000-08-30 |
ID23507A (id) | 2000-04-27 |
PL335054A1 (en) | 2000-03-27 |
SK99199A3 (en) | 2000-05-16 |
US6271217B1 (en) | 2001-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR199901768T2 (tr) | Bir kemoterapötik etken ile bir benzimidazolu ve istege bagli olarak bir potansiyatörü içeren, kanser gelisimini önlemeye yönelik kit. | |
TR199701147T1 (tr) | Kanserlerin gelismesini önlemeye mahsus, benzimidazol içeren bir farmasötik bilesim. | |
TR200200588T2 (tr) | N-pirazol A2A reseptör agonistleri | |
MY144045A (en) | Methods of treating cancer and related methods | |
RS20050975A (en) | Specific binding agents to hepatocyte growth factor | |
HK1038512A1 (en) | Methods of inducing cancer cell death and tumor regression | |
IL195605A0 (en) | Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms | |
TR200101482T2 (tr) | WT1'e özgü imünoterapi için bileşimler | |
AU2472400A (en) | CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies | |
DE69907151D1 (de) | Krebsbehandlung | |
AU2001287157A1 (en) | Promotion of adoptosis in cancer cells by co-administration of cyclin dependent kinase inhibitors and cellular differentiation agents | |
EP0637246A4 (en) | METHODS OF TREATING CANCER WITH C-REACTIVE PROTEIN. | |
IS5025A (is) | Samtengd efnasambönd nytsamleg við meðhöndlunina á krabbameini í blöðruhálskirtli | |
EP1003769A4 (en) | COMPOSITIONS SPECIFICALLY BINDING TO COLORECTAL CANCER CELLS AND METHOD FOR THEIR USE | |
BG106057A (en) | Method of enhancing the efficacy of anti-tumour agents | |
NO20031531D0 (no) | Fremgangsmåter for reduksjon av kreftcelledöd og tumorregresjon | |
TR200003453T2 (tr) | Yeni terkipler | |
DE60043942D1 (de) | Fluoreszierende cobalamine und deren verwendung | |
ATE285247T1 (de) | Krebstherapie mit lymphotoxin | |
NO20012027D0 (no) | Fremgangsmåter og blandinger for selektiv kreft-kjemoterapi | |
BR0108951A (pt) | Uso de exemestano, e método para o tratamento de primeira linha de c ncer de mama | |
AU6617498A (en) | Ascorbic acid as an adjuvant in the treatment of malignant tumors using chemo- and radiotherapy | |
BR0312114A (pt) | Métodos e agentes de contraste úteis para quantificar óxido nìtrico | |
WO2002055555A3 (en) | Antigenic ck-18 compounds for therapy and diagnosis and methods for using same | |
AU9061098A (en) | Method and test kit for detecting malignant tumours |